title: Shall we stop or continue angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to using contrast agents?
authors.affiliation: Department of Nephrology, Shariati Hospital and Transplantation and the Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran. mrezaganji@yahoo.com
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Ganji
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D051436:Renal Insufficiency, Chronic / Q000150:complications*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D003287:Contrast Media